Why the study?
Does torasemide improve heart rate variability and reduce ventricular rhythm disorders compared to furosemide in patients with chronic heart failure complicating ischemic heart disease?
Does torasemide improve heart rate variability and reduce ventricular rhythm disorders compared to furosemide in patients with chronic heart failure complicating ischemic heart disease?
Short-term torasemide therapy improves autonomic regulation and reduces ventricular arrhythmias compared to furosemide in severe heart failure.
Answers are grounded in this paper and cite their sources.
May favor torasemide over furosemide for autonomic and arrhythmic effects in ischemic HF; hypothesis-generating and should not yet change practice.
Aim. To study effect of diuretic therapy with furosemide and torasemide on heart rate variability (HRV) and frequency of ventriclar rhythm disorders in patients with chronic heart failure (CHF) complicating ischemic heart disease (IHD). Material and methods. Patients (n=107) with CHF III-IV functional class (NYHA) complicating IHD were examined. The first group of patients received furosemide, 20-60 mg QD (n=52), the second group received torasemide, 5-20 mg QD (n=55). Analysis of heart rhythm disorders and the basic HRV indicators was performed by ECG 10-minute recordings initially and after 10 days of therapy. Results. Decrease in time and spectral HRV parameters and increase in daily number of ventricular extrasystoles was found in furosemide treated patients. Improvement of HRV parameters and reduction of daily number of ventricular rhythm disorders was found torasemide treated patients. Conclusion. Torasemide therapy improves an autonomic regulation of heart rhythm and leads to the reduction of ventricular heart rhythm disorders in patients with CHF complicating IHD.
No takes yet. Share an insight, caveat, or question.
Shugushev et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: